| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
BI 853520, a FAK-Simile of Prior FAK Inhibitors?
|
Lee, Rachael Chang
|
|
2019
|
14 |
1 |
p. 39-41
|
article
|
| 2 |
Cabozantinib: A Review in Advanced Hepatocellular Carcinoma
|
Deeks, Emma D.
|
|
2019
|
14 |
1 |
p. 107-113
|
article
|
| 3 |
Correction to: Fulvestrant-Based Combination Therapy for Second-Line Treatment of Hormone Receptor-Positive Advanced Breast Cancer
|
Sammons, Sarah
|
|
2018
|
14 |
1 |
p. 13
|
article
|
| 4 |
Development of a Novel EGFR-Targeting Antibody-Drug Conjugate for Pancreatic Cancer Therapy
|
Li, Zhuanglin
|
|
2019
|
14 |
1 |
p. 93-105
|
article
|
| 5 |
Fulvestrant-Based Combination Therapy for Second-Line Treatment of Hormone Receptor-Positive Advanced Breast Cancer
|
Sammons, Sarah
|
|
2018
|
14 |
1 |
p. 1-12
|
article
|
| 6 |
Liquid-Biopsy-Based Identification of EGFR T790M Mutation-Mediated Resistance to Afatinib Treatment in Patients with Advanced EGFR Mutation-Positive NSCLC, and Subsequent Response to Osimertinib
|
Hochmair, Maximilian J.
|
|
2018
|
14 |
1 |
p. 75-83
|
article
|
| 7 |
Outcomes for Metastatic Colorectal Cancer Based on Microsatellite Instability: Results from the South Australian Metastatic Colorectal Cancer Registry
|
Chong, Li Chia
|
|
2019
|
14 |
1 |
p. 85-91
|
article
|
| 8 |
Phase I Study of BI 853520, an Inhibitor of Focal Adhesion Kinase, in Patients with Advanced or Metastatic Nonhematologic Malignancies
|
de Jonge, Maja J. A.
|
|
2019
|
14 |
1 |
p. 43-55
|
article
|
| 9 |
Phase I Study of the Focal Adhesion Kinase Inhibitor BI 853520 in Japanese and Taiwanese Patients with Advanced or Metastatic Solid Tumors
|
Doi, Toshihiko
|
|
2019
|
14 |
1 |
p. 57-65
|
article
|
| 10 |
Phase 2 Multicenter Single-Arm Study of Second-Line Axitinib in Favorable Risk Patients with Metastatic Renal Cell Carcinoma: FavorAx
|
Tsimafeyeu, Ilya
|
|
2019
|
14 |
1 |
p. 33-38
|
article
|
| 11 |
Randomized, Open-Label, Crossover Studies Evaluating the Effect of Food and Liquid Formulation on the Pharmacokinetics of the Novel Focal Adhesion Kinase (FAK) Inhibitor BI 853520
|
Verheijen, Remy B.
|
|
2019
|
14 |
1 |
p. 67-74
|
article
|
| 12 |
The Challenge of Managing Bladder Cancer and Upper Tract Urothelial Carcinoma: A Review with Treatment Recommendations from the Spanish Oncology Genitourinary Group (SOGUG)
|
Font, Albert
|
|
2019
|
14 |
1 |
p. 15-32
|
article
|
Journal description